GemCap Biotech ApS: Financial statements 2018
CVR: 38189174
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
GemCap Biotech ApS (CVR 38189174) has filed annual accounts for 2018. In 2018, the company reported a net result of EUR 0. Equity in the 2018 report amounted to EUR 6,750. The solvency ratio was 100%.
- Profit/Loss
- EUR 0
- Equity
- EUR 6,750
- Total Assets
- EUR 6,750
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
GemCap Biotech ApS has published its interim report for the period November 17, 2016 – December 31, 2017.
About GemCap Biotech ApS
GemCap Biotech ApS was a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2016. The company has been dissolved on 24 March 2024. The company was registered under the industry Anden finansiel formidling undtagen forsikring og pensionsforsikring, i.a.n.. According to the 2023 annual report, the company had an average of 0 employees. In 2023, the company reported a net result of EUR 0 compared with EUR 0 the year before. Equity in the 2023 report amounted to EUR 27,000.